News + Filings Transactions Holdings
|
5AM Ventures V, L.P.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
11/30/2022 | Akouos, Inc. | AKUS | Other | Common Stock | 3.2M | $0.00 | $0 | By 5AM Ventures V, L.P. | 11/30/2022 |
11/30/2022 | Akouos, Inc. | AKUS | Other | Common Stock | 982.5k | $0.00 | $0 | 5AM Opportunities I, L.P. | 11/30/2022 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Common Stock | 318.6k | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Common Stock | 2.4M | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Common Stock | 564.2k | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Common Stock | 254.5k | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Common Stock | 318.1k | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Purchase | Common Stock | 250k | $20.00 | $5M | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Series Seed Preferred Stock | 2.3M | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Series A Preferred Stock | 17.2M | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Series A Preferred Stock | 4.1M | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Series B Preferred Stock | 1.8M | $0.00 | $0 | See footnote | 11/02/2021 |
11/02/2021 | Entrada Therapeutics, Inc. | TRDA | Conversion | Series B Preferred Stock | 2.3M | $0.00 | $0 | See footnote | 11/02/2021 |
11/01/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 258.5k | $13.00 | $3.4M | See footnotes | 11/01/2021 |
11/01/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 36.5k | $13.00 | $475.1k | See footnotes | 11/01/2021 |
09/07/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 625k | $9.70 | $6.1M | See footnotes | 09/07/2021 |
04/22/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (acquisition) | 5% Convertible Note due 2021 | 1.4M | $0.00 | $0 | See Footnote | 04/22/2021 |
01/12/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 74.5k | $13.00 | $968.1k | See footnotes | 01/08/2021 |
01/12/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 10.5k | $13.00 | $136.9k | See footnotes | 01/08/2021 |
01/08/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 264.6k | $13.00 | $3.4M | See footnotes | 01/08/2021 |
01/08/2021 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 37.4k | $13.00 | $486.3k | See footnotes | 01/08/2021 |
12/29/2020 | Akouos, Inc. | AKUS | Sale | Common Stock | 358.4k | $18.00 | $6.5M | Footnote | 12/29/2020 |
12/29/2020 | Akouos, Inc. | AKUS | Sale | Common Stock | 111.6k | $18.00 | $2M | Footnote | 12/29/2020 |
12/10/2020 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 261.1k | $14.75 | $3.9M | See footnotes | 12/10/2020 |
12/10/2020 | Cabaletta Bio, Inc. | CABA | Sale | Common Stock | 36.9k | $14.75 | $544.5k | See footnotes | 12/10/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 513.8k | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 2M | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 1000k | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 800k | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Purchase | Common Stock | 294.1k | $17.00 | $5M | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series Seed Preferred Stock | 10.8M | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series A Preferred Stock | 42.1M | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series B Preferred Stock | 21.1M | $0.00 | $0 | footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series B Preferred Stock | 16.9M | $0.00 | $0 | footnote | 06/30/2020 |
10/29/2019 | Cabaletta Bio, Inc. | CABA | Conversion | Common Stock | 3.2M | $0.00 | $0 | See footnotes | 10/29/2019 |
|
|